ruthenium has been researched along with carboplatin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aird, RE; Davidson, JE; Dawson, A; Fabbiani, FP; Fernandez, R; Habtemariam, A; Jodrell, DI; Melchart, M; Oswald, ID; Parkin, A; Parsons, S; Sadler, PJ | 1 |
| Casari, I; Desai, NM; Falasca, M; Massi, M; Simpson, PV | 1 |
| Ciofi, L; Cirri, D; Fabbrini, MG; Marzo, T; Massai, L; Messori, L; Pratesi, A | 1 |
| Alessio, E; Burckel, P; Gandioso, A; Gasser, G; Vidal, A | 1 |
1 review(s) available for ruthenium and carboplatin
| Article | Year |
|---|---|
Metal-based antitumor compounds: beyond cisplatin.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Copper; Drug Discovery; Gold; Humans; Iridium; Iron; Metals; Neoplasms; Organometallic Compounds; Rhenium; Rhodium; Ruthenium | 2019 |
3 other study(ies) available for ruthenium and carboplatin
| Article | Year |
|---|---|
Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands.
Topics: 2,2'-Dipyridyl; Antineoplastic Agents; Benzene Derivatives; Carboplatin; Cell Line, Tumor; Chelating Agents; Cisplatin; Crystallography, X-Ray; Diamines; Doxorubicin; Drug Screening Assays, Antitumor; Humans; Ligands; Molecular Structure; Organometallic Compounds; Polycyclic Compounds; Ruthenium; Structure-Activity Relationship | 2006 |
The leading established metal-based drugs: a revisitation of their relevant physico-chemical data.
Topics: Auranofin; Carboplatin; Cisplatin; Coordination Complexes; Gold; Gold Sodium Thiomalate; Merbromin; Mercury; Oxaliplatin; Phenylmercury Compounds; Platinum; Ruthenium | 2019 |
Ruthenium(II) Polypyridyl Complexes Containing Simple Dioxo Ligands: a Structure-Activity Relationship Study Shows the Importance of the Charge.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Coordination Complexes; Humans; Ligands; Malonates; Neoplasms; Oxalates; Platinum; Ruthenium; Structure-Activity Relationship | 2022 |